Citation: Jd. Lalau et Jm. Race, Lactic acidosis in metformin therapy: searching for a link with metformin in reports of 'metformin-associated lactic acidosis', DIABET OB M, 3(3), 2001, pp. 195-201
Authors:
Bourquelot, P
Buisson, C
Chanard, J
Cordonnier, D
Drueke, T
Dupuy, CA
Gin, H
Halimi, S
Hannedouche, T
Jacobs, C
Kourilsky, O
Lalau, JD
Pirson, Y
Ryckelynck, JP
Vialettes, B
Citation: P. Bourquelot et al., Report of the expert committee. ALFEDIAM and SFN. Management of end stage renal disease in diabetic patients. Short text, DIABETE MET, 26(1), 2000, pp. 81-87
Authors:
Bourquelot, P
Buisson, C
Chanard, J
Cordonnier, D
Drueke, T
Dupuy, CA
Gin, H
Halimi, S
Hannedouche, T
Jacobs, C
Kourilsky, O
Lalau, JD
Pirson, Y
Vialettes, B
Citation: P. Bourquelot et al., Management of Uremic Diabetes - Guidelines for Clinical Practice - Joint report of ALFEDIAM and the Societe de Nephrologie, DIABETE MET, 25, 1999, pp. 7-72
Citation: Jd. Lalau et Jm. Race, Lactic acidosis in metformin-treated patients - Prognostic value of arterial lactate levels and plasma metformin concentrations, DRUG SAFETY, 20(4), 1999, pp. 377-384
Authors:
Beck-Nielsen, H
Skyler, J
Hanefeld, M
Eschwege, E
Finn, JR
DeFronzo, R
Del Prato, S
Bjorntorp, P
Groop, L
Haring, H
Zimmet, P
Riou, JP
Vague, P
Reaven, G
Bailey, CJ
Iselin, HU
Wiernsperger, N
Pugeat, M
Garber, A
Taskinen, MR
Laube, H
Yki-Jarvinen, H
Consoli, A
Harter, M
Lalau, JD
Charles, A
Citation: H. Beck-nielsen et al., Prevention of type 2 diabetes - Role of metformin - Discussion, DRUGS, 58, 1999, pp. 75-82